Latest Observability News

Apollo Minerals has launched Phase 2 drilling at its Salanie Gold Project in Gabon, building on strong 2024 results that revealed high-grade gold mineralisation and visible gold. The program targets extensions at A1 and new prospects A2, A3, and P6.

A new peer-reviewed study highlights Cynata Therapeutics’ Cymerus™ iPSC-derived MSCs as superior to traditional donor tissue-derived MSCs in potency, consistency, and regenerative potential.

Strickland Metals has reported multiple high-grade gold intercepts from its Gradina Prospect in Serbia, confirming extensive mineralisation and paving the way for a maiden Mineral Resource Estimate later this year.

Meteoric Resources reports exceptional rare earth element grades and enriched magnetic rare earth oxides at its Agostinho Prospect in Brazil, signaling a potential expansion of its Caldeira Project resource base.

Argenica Therapeutics reports compelling preclinical evidence that its lead candidate ARG-007 significantly reduces brain cell damage and inflammation in moderate traumatic brain injury models, marking a promising step toward new TBI treatments.

Argenica Therapeutics has reported compelling preclinical data showing ARG-007 significantly reduces brain cell damage and inflammation in moderate traumatic brain injury, matching levels seen in uninjured controls. This reinforces ARG-007’s potential as a breakthrough neuroprotective therapy.

Sigma Healthcare has received Federal Court approval for its acquisition of Chemist Warehouse, marking a pivotal step in its strategic expansion. The scheme is set to become legally effective on February 4, 2025, with implementation expected by February 12.

Alpha HPA Limited has announced key leadership changes, appointing Rob Williamson as Managing Director to steer the company through its next growth phase, while Rimas Kairaitis shifts focus to commercial strategy. The retirement of long-serving director Peter Nightingale marks the end of an era.

Alterity Therapeutics has raised over A$2 million through its U.S. ATM facility and expects nearly A$5.7 million in Australian tax rebates, fueling the advancement of its lead neurodegenerative drug candidate ATH434 following promising Phase 2 results.

OzAurum Resources has announced a significant new high-grade gold discovery at its Mulgabbie North Gold Project in Western Australia, revealing multiple shallow intercepts that could expand its existing resource base.

Nova Minerals' 2024 exploration at the RPM Regional area reveals high-grade gold samples, including a standout 52.3 g/t Au, highlighting significant resource potential at the Estelle Project in Alaska.

Cobre Limited reports promising assay results from diamond drilling at its Ngami Copper Project in Botswana, revealing significant copper and silver mineralization over a 4km strike. The findings bolster prospects for advancing the Comet target towards a formal resource estimate.